CLRB - Cellectar Biosciences, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.68
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.3300
52 Week Low 31.0100
50-Day Moving Average 31.3774
200-Day Moving Average 31.7042

Share Statistics

Avg Vol (3 month) 31.15M
Avg Vol (10 day) 32.48M
Shares Outstanding 524M
Float 7.88M
% Held by Insiders 12.58%
% Held by Institutions 129.70%
Shares Short (Jul 14, 2020) 4291.53k
Short Ratio (Jul 14, 2020) 40.38
Short % of Float (Jul 14, 2020) 41.22%
Short % of Shares Outstanding (Jul 14, 2020) 41.21%
Shares Short (prior month Jun 14, 2020) 460.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-84.91%
Return on Equity (ttm)-191.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.29M
Net Income Avi to Common (ttm)-14.43M
Diluted EPS (ttm)-1.6340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.09M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)502.21k
Total Debt/Equity (mrq)9.57
Current Ratio (mrq)2.58
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-12.39M
Levered Free Cash Flow (ttm)-7.44M